Celltrion
068270.KS
#821
Rank
โ‚ฌ25.38 B
Marketcap
116,05ย โ‚ฌ
Share price
-12.27%
Change (1 day)
0.54%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚ฌ25.38 Billion

As of March 2026 Celltrion has a market cap of โ‚ฌ25.38 Billion. This makes Celltrion the world's 821th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ25.38 B9.29%
2025โ‚ฌ23.23 B-8.39%
2024โ‚ฌ25.35 B-16.27%
2023โ‚ฌ30.28 B79.19%
2022โ‚ฌ16.90 B-17.45%
2021โ‚ฌ20.47 B-44.15%
2020โ‚ฌ36.65 B106.25%
2019โ‚ฌ17.77 B-18.13%
2018โ‚ฌ21.70 B1.2%
2017โ‚ฌ21.45 B107.57%
2016โ‚ฌ10.33 B39.82%
2015โ‚ฌ7.39 B148.23%
2014โ‚ฌ2.97 B15.29%
2013โ‚ฌ2.58 B-21.37%
2012โ‚ฌ3.28 B16.83%
2011โ‚ฌ2.81 B8.49%
2010โ‚ฌ2.59 B181.57%
2009โ‚ฌ0.92 B59.55%
2008โ‚ฌ0.57 B4409.11%
2007โ‚ฌ12.79 M